|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
1780
|
(R)-Desethyl-Etomidate
|
1780.0003: 3 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for [11C]Metomidate, [11C]Etomidate, and (R)-[18F]FETO
(R)-[18F]Fluoroethyletomidate
|
|
|
|
|
|
|
|
|
Molar Mass: 216.24
|
|
|
C12H12N2O2
|
|
|
[56649-48-0]
|
|
|
|
|
|
Off-white solid packaged in dark glass crimp cap vials.
|
|
|
|
|
|
|
|
|
Purity: > 95 %
|
|
|
Certificates:
CoA; 1H NMR spectrum
|
|
|
Chemical Name:
CA index name: 1H-Imidazole-5-carboxylic acid, 1-[(1R)-1-phenylethyl]-
|
|
|
Synonymes:
(R)-(+)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid; 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, (R)-; 1H-Imidazole-5-carboxylic acid, 1-[(1R)-1-phenylethyl]-; R28141;
|
|
|
Literature:
1. Bergström M. et al. In Vitro and In Vivo Primate Evaluation of Carbon-11-Etomidate and Carbon-11-Metomidate as Potential Tracers for PET Imaging of the Adrenal Cortex and Its Tumors. J. Nucl. Med. 1998, 39, 982-989.
|
|
|
2. Wadsak W. et al. Synthesis of [18F]FETO, a novel potential 11-beta hydroxylase inhibitor. J. Labelled Compd. Radiopharm. 2003, 46, 379-388.
|
|
|
3. Mitterhauser M. et al. In vivo and in vitro evaluation of [18F]FETO with respect to the adrenocortical and GABAergic system in rats. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 1398-1401.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|